PD Andreas  Roos (PhD)
Translational Research in Neuromuscular Disorders

PD Dr. rer. nat. Andreas Roos

Research Coordinator - Dept. of Neuropediatrics, University of Duisburg-Essen 🡵

Adjunct Professor - University of Ottawa 🡵

Project Manager - NMD-GPS 🡵

GENOMIC AND PROTEOMIC SIGNATURES AS A GPS IN NEUROMUSCULAR DISEASES



Welcome dear visitor

As senior scientist I am working in the field of translational medicine with a main focus on neurodegenerative and neuromuscular disorders.

In order to understand the etiology of these diseases and to obtain a full picture, my work focusses on the identification of the genetic cause as well as on the discovery of the related pathophysiological consequences. For the latter purpose, various biochemical techniques including different proteomic approaches are applied by making use of in vitro and in vivo models as well as of patient-derived material.

I'd like to invite you to discover my field activity and related projects.

Best regards

Andreas Roos

 

News


Zurück zur Übersicht

09.01.2024

Recently published paper

European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy. March 17-19, 2023, Barcelona, Spain.
Neuromuscul Disord.
~
Smeets H, Verbrugge B, Bulbena X, Hristova L, Vogt J, van Beckhoven I; on behalf of all participants (Allamand V, Almekinders J, Barquinero J, Berreur S, Bönnemann C, Bouman K, de Bruin L, Caron L, Damon C, Durbeej M, Feijen D, Foley R, Goncalves AR, Camelo CG, Güell M, Haliloglu G, Kemaladewi D, Klein A, Koleda N, Minko O, Munell F, Nebermann T, Pini V, Previtali S, Roos A, Rüegg M, Sarkozy A, Seferian A, Stepniewski J, van Straten E, van Tienen F, Quijano-Roy S, Voermans N, West A, Yurchenco P); Patient organizations/patient representatives: LAMA2-Europe, Voor Sara-the Netherlands, ImpulsaT-Spain, LAMA2-France, CMD-Turkey, LAMA2-Bulgaria, Cure-CMD.
2024 Jan 9;36:16-22. (Online ahead of print).
PMID:38306718
doi: 10.1016/j.nmd.2024.01.001



Zurück zur Übersicht